))
Episode 3 | Racing Against Resistance: The Future of Antimicrobial Innovation
Manage episode 516322104 series 3682949
Content provided by tranScrip. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by tranScrip or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Rienk Pypstra, tranScrip’s Chief Medical Officer, joins Marc Lemonnier, Chief Executive Officer of Antabio, to discuss the global threat of antimicrobial resistance. They’ll explore why innovation must outpace bacterial evolution, how economic incentives can sustain antibiotic R&D, and why agility, collaboration, resilience and strategic vision are essential to overcoming resistance and driving the future of AMR.
3 episodes
Share
